Vanguard Group Inc Alpine Immune Sciences, Inc. Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.75 - $41.6 $8.48 Million - $19.9 Million	477,518 Added 21.37%	2,712,285 $108 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $6.49 Million - $15.4 Million	759,888 Added 51.52%	2,234,767 $42.6 Million
Q3 2023 Nov 14, 2023	BUY	$10.13 - $13.98 $718,338 - $991,349	70,912 Added 5.05%	1,474,879 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $234,324 - $408,012	34,258 Added 2.5%	1,403,967 $14.4 Million
Q1 2023 May 15, 2023	BUY	$7.0 - $8.75 $64,442 - $80,552	9,206 Added 0.68%	1,369,709 $10.6 Million
Q4 2022 Feb 10, 2023	BUY	$5.45 - $7.35 $1.3 Million - $1.75 Million	237,703 Added 21.17%	1,360,503 $10 Million
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $3.4 Million - $4.63 Million	493,027 Added 78.29%	1,122,800 $8.08 Million
Q2 2022 Aug 12, 2022	SELL	$6.71 - $9.52 $522,205 - $740,894	-77,825 Reduced 11.0%	629,773 $5.36 Million
Q1 2022 May 13, 2022	BUY	$6.41 - $13.89 $63,100 - $136,733	9,844 Added 1.41%	707,598 $6.35 Million
Q4 2021 Feb 14, 2022	BUY	$10.41 - $13.95 $1.22 Million - $1.64 Million	117,276 Added 20.2%	697,754 $9.66 Million
Q3 2021 Nov 12, 2021	BUY	$8.19 - $11.31 $43,087 - $59,501	5,261 Added 0.91%	580,478 $6.19 Million
Q2 2021 Aug 13, 2021	BUY	$8.81 - $15.03 $5.07 Million - $8.65 Million	575,217 New	575,217 $5.18 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.